Comments

Estrella Immunopharma (ESLA) Stock Price, Quote, News & History

ESLANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$1.81

0.084.62%

At close: Dec 15, 4:00 PM EST

$2.12

0.3117.13%

After Hours: Dec 10, 6:56 AM EST

Overview

News Earnings Analyst Ratings Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.73

$1.81

Volume / Avg.

46.00K / 281.14K

Day Range

$1.73 - $1.94

52 Wk Range

0.73 - 3.15

Market Cap

$80.06M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.72%

Days to Cover

2.76

Recent Estrella Immunopharma Inc News

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$1.73

$1.81

Volume / Avg.

46.00K / 281.14K

Day Range

$1.73 - $1.94

52 Wk Range

0.73 - 3.15

Market Cap

$80.06M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

4.72%

Days to Cover

2.76

About

Sector

Health Care

Industry

Biotechnology

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry